期刊文献+

幽门螺杆菌根治性治疗在胃癌合并幽门螺杆菌感染的临床效果 被引量:3

下载PDF
导出
摘要 目的:探讨胃癌合并幽门螺杆菌(Hp)阳性患者采取Hp根治性治疗对患者化疗疗效及不良反应发生的影响。方法:选取2017年3月至2019年2月郑州人民医院行胃癌化疗合并Hp阳性患者72例进行研究,用随机分组法将患者分为对照组(常规化疗,36例)和观察组(常规化疗联合Hp根治性治疗,36例),比较两组患者化疗疗效及不良反应发生率。结果:观察组患者的治疗总有效率为63.89%高于对照组的30.56%,差异具有统计学意义(P<0.05);观察组患者的恶心呕吐、头晕发生率低于对照组,差异具有统计学意义(P<0.05)。结论:胃癌化疗合并Hp阳性患者采取Hp根治性治疗,能协助提高患者化疗效果,降低化疗相关不良反应发生率。
机构地区 郑州人民医院
出处 《深圳中西医结合杂志》 2020年第14期153-154,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献3

二级参考文献31

  • 1胡立民.幽门螺杆菌的致病机制[J].临床军医杂志,2004,32(6):117-118. 被引量:3
  • 2Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide~ sources, methods and major patterns inGLOBOCAN2012[J]. Int J Cancer, 2015,136(5):E359- E386. DOI: 10. 1002/ijc. 29210. 被引量:1
  • 3Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version2. 2013: featured updates to the NCCN Guidelines[J].J Natl Compr Cane Netw, 2013,11(5):531-546. 被引量:1
  • 4Leung WK, Wu MS, Kakugawa Y,et al. Screening for gastric cancer in Asia: current evidence and practice[J].Lancet Oncol, 2008,9(3): 279-287. DOI:10. 1016/S1470-2045(08) 70072-X. 被引量:1
  • 5Miki K. Gastric cancer screening by combined assay tot serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels--"ABC method" [J]. Proc Jpn Acad Ser B Phys Biol Sci, 2011,87(7) :405-414. 被引量:1
  • 6Dixon MF, Genta RM, Yardley JH,et al. Classification and grading of gastritis. The up~lated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994 [J]. Am J Surg Pathol, 1996,20(10) :1161-1181. 被引量:1
  • 7Zhang X, Xue L, Xing L, et al. Low serum pepsinogen I and pepsinogen I/1I ratio and Helicohacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community[J]. Int J Cancer, 2012, 130(7):614- 1619. DOI..10. 1002/ijc. 26172. 被引量:1
  • 8Cao XY, Jia ZF, Jin MS, et al. Serum pepsinogen 1I is a ~etter diagnostic marker in gastric cancer[J].World J 3astroenterol, 2012, 18(48) : 7357-7361. 被引量:1
  • 9Je Vries AC, van Grieken NC, Looman CW, et al. Gastric :ancer risk in patients with premalignant gastric lesions: a lationwide cohort study in the Netherlands [J].}astroenterology, 2008, 134 (4): 945-952. 被引量:1
  • 10shafaghi A, Mansour Ghanaei F, Joukar F, et al. Serum :astrin and the pepsinogen I / 1I ratio as markers for diagnosisof premalignant gastric lesions[J]. Asian Pac J Cancer Prev, 2013,14(6):3931 3936. 被引量:1

共引文献84

同被引文献26

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部